GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » EV-to-Revenue

Tatva Chintan Pharma Chem (BOM:543321) EV-to-Revenue : 6.44 (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Tatva Chintan Pharma Chem's enterprise value is ₹25,329 Mil. Tatva Chintan Pharma Chem's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹3,935 Mil. Therefore, Tatva Chintan Pharma Chem's EV-to-Revenue for today is 6.44.

The historical rank and industry rank for Tatva Chintan Pharma Chem's EV-to-Revenue or its related term are showing as below:

BOM:543321' s EV-to-Revenue Range Over the Past 10 Years
Min: 6   Med: 11.28   Max: 14.83
Current: 6.44

During the past 6 years, the highest EV-to-Revenue of Tatva Chintan Pharma Chem was 14.83. The lowest was 6.00. And the median was 11.28.

BOM:543321's EV-to-Revenue is ranked worse than
88.86% of 1535 companies
in the Chemicals industry
Industry Median: 1.58 vs BOM:543321: 6.44

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Tatva Chintan Pharma Chem's stock price is ₹1097.65. Tatva Chintan Pharma Chem's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹172.27. Therefore, Tatva Chintan Pharma Chem's PS Ratio for today is 6.37.


Tatva Chintan Pharma Chem EV-to-Revenue Historical Data

The historical data trend for Tatva Chintan Pharma Chem's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem EV-to-Revenue Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial - - 11.99 9.06 6.33

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.06 9.11 7.94 8.93 6.33

Competitive Comparison of Tatva Chintan Pharma Chem's EV-to-Revenue

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's EV-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's EV-to-Revenue falls into.



Tatva Chintan Pharma Chem EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Tatva Chintan Pharma Chem's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=25328.549/3935.05
=6.44

Tatva Chintan Pharma Chem's current Enterprise Value is ₹25,329 Mil.
Tatva Chintan Pharma Chem's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,935 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tatva Chintan Pharma Chem  (BOM:543321) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Tatva Chintan Pharma Chem's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1097.65/172.27
=6.37

Tatva Chintan Pharma Chem's share price for today is ₹1097.65.
Tatva Chintan Pharma Chem's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹172.27.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tatva Chintan Pharma Chem EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem (BOM:543321) Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines